TITLE

Clopidogrel unaffected by CYP2C19 loss-of-function alleles in patients with ACS, AF

PUB. DATE
December 2010
SOURCE
Cardiology Today;Dec2010, Vol. 13 Issue 12, p34
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports that the effect of clopidogrel compared with placebo has remained consistent regardless of CYP2C19 loss-of-function allele status for patients with acute coronary syndromes or atrial fibrillation, according to data from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A) randomized trials.
ACCESSION #
55545929

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics